News
Company ImmuPharma PLC
TIDM IMM
Headline Directors' Dealings
Released 07:00 23-Mar-2009
Number 2575P07
FOR IMMEDIATE RELEASE
London, 23 March 2009
Directors' Dealings
Institutions increase stake
ImmuPharma PLC ("ImmuPharma" or the "Company") (LSE:IMM) announces today that a number of existing and new blue-chip institutional investors have purchased shares from the Trusts of two of ImmuPharma's founders and Directors, Richard Warr and Dimitri Dimitriou. The Trusts each placed 2.1 million (2.7 %) ordinary shares of 10 pence each in the Company at a price of 82 pence per share to institutional investors on 19 March.
Following the disposal, the current holdings are:
Richard Warr (1)
9,778,968 ordinary shares
(12.6 %)
Dimitri Dimitriou (2)
9,778,969 ordinary shares
(12.6 %)
(1) Ordinary shares of £0.10 held by Louvre Trustees Limited where
the Warr family has a beneficial interest.
(2) Ordinary shares of £0.10 held by Louvre Trustees Limited where the
Dimitriou family has a beneficial interest.
Richard Warr, ImmuPharma's Chairman said: "We are delighted with the demand from new investors, including several blue-chip funds such as Gartmore, Smith & Williamson, Aviva and Rathbones. The allocation of these shares increases ImmuPharma's free float with the aim of improving overall liquidity."
For further information please contact:
ImmuPharma PLC +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman
Panmure Gordon & Co 44 151 243 0963
Andrew Burnett / Rakesh Sharma (Corporate Finance)
Ashton Clanfield (Corporate Broking)
Buchanan Communications +44 20 7466 5000
Lisa Baderoon
Rebecca Skye Dietrich
© London Stock Exchange plc. All rights reserved